Cairo: Minapharm Pharmaceuticals has announced the closure of an EGP 95.52 million deal to buy a 15.76% stake in its subsidiary, Minapharm Probiogen from Triquetra B.V.
The Egypt-listed company has acquired 4,871 of Minapharm Probiogen’s shares, according to a bourse statement.
Following the deal, Minapharm Pharmaceuticals’ stake in the subsidiary will be increased to 75.01% from 59.25%.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2018 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
